Levetiracetam as a treatment for tardive dyskinesi... [Neurology. 2003] - PubMed

loading

Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam: a case series. [J Clin Psychopharmacol. 2006]
Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam: a case series.
Bona JR. J Clin Psychopharmacol. 2006 Apr; 26(2):215-6.
Levetiracetam in tardive dyskinesia. [Clin Neuropharmacol. 2006]
Levetiracetam in tardive dyskinesia.
Meco G, Fabrizio E, Epifanio A, Morgante F, Valente M, Vanacore N, Di Rosa AE, Morgante L. Clin Neuropharmacol. 2006 Sep-Oct; 29(5):265-8.
Treatment of tardive dyskinesia with levetiracetam in a transplant patient. [Acta Neurol Scand. 2008]
Treatment of tardive dyskinesia with levetiracetam in a transplant patient.
Zivković SA, Costa G, Bond G, Abu-Elmagd KM. Acta Neurol Scand. 2008 May; 117(5):351-3. Epub 2007 Nov 8.
Review Migraine preventive therapy: current and emerging treatment options. [Neurol Sci. 2005]
Review Migraine preventive therapy: current and emerging treatment options.
Rapoport AM, Bigal ME. Neurol Sci. 2005 May; 26 Suppl 2:s111-20.
Review [The possibilities of using keppra (levetiracetam) in different neurological diseases]. [Zh Nevrol Psikhiatr Im S S Kor...]
Review [The possibilities of using keppra (levetiracetam) in different neurological diseases].
Lebedeva AV, Nemenov DG. Zh Nevrol Psikhiatr Im S S Korsakova. 2008; Suppl 2:49-56.

Levetiracetam reverses synaptic deficits produced by overexpression of SV2A. [PLoS One. 2011]
Levetiracetam reverses synaptic deficits produced by overexpression of SV2A.
Nowack A, Malarkey EB, Yao J, Bleckert A, Hill J, Bajjalieh SM. PLoS One. 2011; 6(12):e29560. Epub 2011 Dec 29.
SV2 regulates neurotransmitter release via multiple mechanisms. [Am J Physiol Cell Physiol. 2010]
SV2 regulates neurotransmitter release via multiple mechanisms.
Nowack A, Yao J, Custer KL, Bajjalieh SM. Am J Physiol Cell Physiol. 2010 Nov; 299(5):C960-7. Epub 2010 Aug 11.
Cotrafficking of SV2 and synaptotagmin at the synapse. [J Neurosci. 2010]
Cotrafficking of SV2 and synaptotagmin at the synapse.
Yao J, Nowack A, Kensel-Hammes P, Gardner RG, Bajjalieh SM. J Neurosci. 2010 Apr 21; 30(16):5569-78.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Levetiracetam as a treatment for tardive dyskinesia: a case report.
Levetiracetam as a treatment for tardive dyskinesia: a case report.
Neurology. 2003 Aug 12 ;61(3):419.

PubMed
Convergent responses to stress. Solar ultraviolet-B radiation and Manduca sexta ...
Convergent responses to stress. Solar ultraviolet-B radiation and Manduca sexta herbivory elicit overlapping transcriptional responses in field-grown plants of Nicotiana longiflora.
Plant Physiol. 2003 Aug ;132(4):1755-67.

PubMed
Dual recognition of the ribosome and the signal recognition particle by the SRP ...
Dual recognition of the ribosome and the signal recognition particle by the SRP receptor during protein targeting to the endoplasmic reticulum.
J Cell Biol. 2003 Aug 18 ;162(4):575-85. Epub 2003 Aug 11 .

PubMed
Clindamycin versus phenoxymethylpenicillin in the treatment of acute orofacial i...
Clindamycin versus phenoxymethylpenicillin in the treatment of acute orofacial infections.
Eur J Clin Microbiol Infect Dis. 1992 Dec ;11(12):1129-35.

PubMed
Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to ...
Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia.
Hum Mol Genet. 2003 Aug 15 ;12(16):2063-76.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed